Inspire Medical Systems Price to Sales Ratio 2017-2024 | INSP
Inspire Medical Systems P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-01-07 | 215.42 | 8.55 | |
2024-09-30 | 211.05 | $25.18 | 8.38 |
2024-06-30 | 133.83 | $23.77 | 5.63 |
2024-03-31 | 214.79 | $22.50 | 9.55 |
2023-12-31 | 203.43 | $21.36 | 9.53 |
2023-09-30 | 198.44 | $19.70 | 10.07 |
2023-06-30 | 324.64 | $18.35 | 17.70 |
2023-03-31 | 234.07 | $16.49 | 14.20 |
2022-12-31 | 251.88 | $14.61 | 17.24 |
2022-09-30 | 177.37 | $12.58 | 14.10 |
2022-06-30 | 182.67 | $10.97 | 16.65 |
2022-03-31 | 256.69 | $9.60 | 26.73 |
2021-12-31 | 230.06 | $8.57 | 26.86 |
2021-09-30 | 232.88 | $7.46 | 31.24 |
2021-06-30 | 193.26 | $6.53 | 29.59 |
2021-03-31 | 206.99 | $5.05 | 40.99 |
2020-12-31 | 188.09 | $4.45 | 42.30 |
2020-09-30 | 129.05 | $3.81 | 33.85 |
2020-06-30 | 87.02 | $3.35 | 25.99 |
2020-03-31 | 60.28 | $3.64 | 16.54 |
2019-12-31 | 74.21 | $3.45 | 21.49 |
2019-09-30 | 61.02 | $3.46 | 17.64 |
2019-06-30 | 60.65 | $3.20 | 18.96 |
2019-03-31 | 56.78 | $3.25 | 17.48 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $5.669B | $0.625B |
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
Tempus AI (TEM) | United States | $5.393B | 0.00 |
IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
Enovis (ENOV) | United States | $2.475B | 16.78 |
Privia Health (PRVA) | United States | $2.357B | 196.40 |
Azenta (AZTA) | United States | $2.286B | 122.05 |
Omnicell (OMCL) | United States | $2.053B | 67.15 |
10x Genomics (TXG) | United States | $1.718B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
Schrodinger (SDGR) | United States | $1.486B | 0.00 |
Phreesia (PHR) | United States | $1.464B | 0.00 |
Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
Standard BioTools (LAB) | United States | $0.651B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
Talkspace (TALK) | United States | $0.529B | 0.00 |
Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
TruBridge (TBRG) | United States | $0.297B | 86.52 |
Pulmonx (LUNG) | United States | $0.257B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
American Well (AMWL) | United States | $0.108B | 0.00 |
P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
HeartBeam (BEAT) | United States | $0.063B | 0.00 |
CareCloud (CCLD) | United States | $0.062B | 0.00 |
Outset Medical (OM) | United States | $0.061B | 0.00 |
111 (YI) | China | $0.054B | 0.00 |
Zepp Health (ZEPP) | China | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.043B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
Movano (MOVE) | United States | $0.035B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
Precipio (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |